Comparative Study of Intact Parathyroid Hormone, Calcium, Phosphate And Radiological Changes In Patients With End Stage Renal Disease On Maintenance Haemodialysis And Newly Diagnosed End Stage Renal Disease

Summary: Secondary hyperparathyroidism and renal bone disease are invariable consequences of chronic kidney disease. Calcitriol deficiency, hypocalcemia and hyperphosphatemia are responsible for raised parathyroid hormone and renal bone disease in both pre-dialysis and maintenance dialysis patients....

Full description

Saved in:
Bibliographic Details
Main Authors: Hada, Rajani, Dr., Khakurel, Sudha, Dr., Agrawal, Rajendra Kumar, Dr.
Format: Technical Report
Language:en_US
Published: NATIONAL ACADEMY OF MEDICAL SCIENCES 2013
Online Access:http://103.69.126.140:8080/handle/123456789/398
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:103.69.126.140:123456789-398
record_format dspace
spelling oai:103.69.126.140:123456789-3982022-11-09T05:36:18Z Comparative Study of Intact Parathyroid Hormone, Calcium, Phosphate And Radiological Changes In Patients With End Stage Renal Disease On Maintenance Haemodialysis And Newly Diagnosed End Stage Renal Disease Hada, Rajani, Dr. Khakurel, Sudha, Dr. Agrawal, Rajendra Kumar, Dr. Summary: Secondary hyperparathyroidism and renal bone disease are invariable consequences of chronic kidney disease. Calcitriol deficiency, hypocalcemia and hyperphosphatemia are responsible for raised parathyroid hormone and renal bone disease in both pre-dialysis and maintenance dialysis patients. Calcitriol therapy and control of serum phosphate with protein restricted diet and phosphate binders result in correction of hyperparathyroidism and reversion of the renal bone histology. Since the initiation of nephrology service in Nepal, these therapies are practiced in all chronic kidney disease patients without any studies on the severity of hyperparathyroidism, renal bone disease and the beneficial and adverse effects of these drugs. So this study was carried out to initiate the study on renal bone disease and to see the degree of hyperparathyroidism, hypocalcemia, hyperphophatemia and the radiological changes in Nepalese patients with end stage renal disease on maintenance haemodialysis (ESRD on MHD) and newly diagnosed end stage renal disease (NESRD) and to evaluate the beneficial effect of haemodialysis on secondary hyperparathyroidism. Twenty three (16 male, 7 female) ESRD on MHD patients with twice a week dialysis for 6 to 78 (22 +3, mean +SEM) months with protein restricted diet and calcium acetate as a phosphate binder but without calcitriol therapy and twenty three ( 16 male, 7 female) NERSD patients without protein restricted diet, phosphate binder and calcitriol therapy were included in this study and fasting blood samples were collected for estimation of serum intact parathyroid hormone (PTH), calcium, phosphate and alkaline phosphatase and all were subjected to X-ray hands A/P view and X-ray lumbosacral spine lateral view. 2013-01-04T19:10:18Z 2022-11-08T10:14:43Z 2013-01-04T19:10:18Z 2022-11-08T10:14:43Z 2005 Technical Report http://103.69.126.140:8080/handle/123456789/398 en_US application/pdf NATIONAL ACADEMY OF MEDICAL SCIENCES
institution My University
collection DSpace
language en_US
description Summary: Secondary hyperparathyroidism and renal bone disease are invariable consequences of chronic kidney disease. Calcitriol deficiency, hypocalcemia and hyperphosphatemia are responsible for raised parathyroid hormone and renal bone disease in both pre-dialysis and maintenance dialysis patients. Calcitriol therapy and control of serum phosphate with protein restricted diet and phosphate binders result in correction of hyperparathyroidism and reversion of the renal bone histology. Since the initiation of nephrology service in Nepal, these therapies are practiced in all chronic kidney disease patients without any studies on the severity of hyperparathyroidism, renal bone disease and the beneficial and adverse effects of these drugs. So this study was carried out to initiate the study on renal bone disease and to see the degree of hyperparathyroidism, hypocalcemia, hyperphophatemia and the radiological changes in Nepalese patients with end stage renal disease on maintenance haemodialysis (ESRD on MHD) and newly diagnosed end stage renal disease (NESRD) and to evaluate the beneficial effect of haemodialysis on secondary hyperparathyroidism. Twenty three (16 male, 7 female) ESRD on MHD patients with twice a week dialysis for 6 to 78 (22 +3, mean +SEM) months with protein restricted diet and calcium acetate as a phosphate binder but without calcitriol therapy and twenty three ( 16 male, 7 female) NERSD patients without protein restricted diet, phosphate binder and calcitriol therapy were included in this study and fasting blood samples were collected for estimation of serum intact parathyroid hormone (PTH), calcium, phosphate and alkaline phosphatase and all were subjected to X-ray hands A/P view and X-ray lumbosacral spine lateral view.
format Technical Report
author Hada, Rajani, Dr.
Khakurel, Sudha, Dr.
Agrawal, Rajendra Kumar, Dr.
spellingShingle Hada, Rajani, Dr.
Khakurel, Sudha, Dr.
Agrawal, Rajendra Kumar, Dr.
Comparative Study of Intact Parathyroid Hormone, Calcium, Phosphate And Radiological Changes In Patients With End Stage Renal Disease On Maintenance Haemodialysis And Newly Diagnosed End Stage Renal Disease
author_facet Hada, Rajani, Dr.
Khakurel, Sudha, Dr.
Agrawal, Rajendra Kumar, Dr.
author_sort Hada, Rajani, Dr.
title Comparative Study of Intact Parathyroid Hormone, Calcium, Phosphate And Radiological Changes In Patients With End Stage Renal Disease On Maintenance Haemodialysis And Newly Diagnosed End Stage Renal Disease
title_short Comparative Study of Intact Parathyroid Hormone, Calcium, Phosphate And Radiological Changes In Patients With End Stage Renal Disease On Maintenance Haemodialysis And Newly Diagnosed End Stage Renal Disease
title_full Comparative Study of Intact Parathyroid Hormone, Calcium, Phosphate And Radiological Changes In Patients With End Stage Renal Disease On Maintenance Haemodialysis And Newly Diagnosed End Stage Renal Disease
title_fullStr Comparative Study of Intact Parathyroid Hormone, Calcium, Phosphate And Radiological Changes In Patients With End Stage Renal Disease On Maintenance Haemodialysis And Newly Diagnosed End Stage Renal Disease
title_full_unstemmed Comparative Study of Intact Parathyroid Hormone, Calcium, Phosphate And Radiological Changes In Patients With End Stage Renal Disease On Maintenance Haemodialysis And Newly Diagnosed End Stage Renal Disease
title_sort comparative study of intact parathyroid hormone, calcium, phosphate and radiological changes in patients with end stage renal disease on maintenance haemodialysis and newly diagnosed end stage renal disease
publisher NATIONAL ACADEMY OF MEDICAL SCIENCES
publishDate 2013
url http://103.69.126.140:8080/handle/123456789/398
work_keys_str_mv AT hadarajanidr comparativestudyofintactparathyroidhormonecalciumphosphateandradiologicalchangesinpatientswithendstagerenaldiseaseonmaintenancehaemodialysisandnewlydiagnosedendstagerenaldisease
AT khakurelsudhadr comparativestudyofintactparathyroidhormonecalciumphosphateandradiologicalchangesinpatientswithendstagerenaldiseaseonmaintenancehaemodialysisandnewlydiagnosedendstagerenaldisease
AT agrawalrajendrakumardr comparativestudyofintactparathyroidhormonecalciumphosphateandradiologicalchangesinpatientswithendstagerenaldiseaseonmaintenancehaemodialysisandnewlydiagnosedendstagerenaldisease
_version_ 1761501076169687040